Cite
APA Citation
Levy, B., Drilon, A., Chachoua, A., Seetharamu, N., Richardson, S., Lucido, D., Legasto, A., Grossbard, M., & Becker, D. (2013). kRAS mutations predict sensitivity to pemetrexed-based chemotherapy. Lung cancer management, 2, 275–280. http://access.bl.uk/ark:/81055/vdc_100136019841.0x00000f